{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:45:28Z","timestamp":1760316328430,"version":"build-2065373602"},"reference-count":40,"publisher":"Wiley","issue":"S4","license":[{"start":{"date-parts":[[2010,2,2]],"date-time":"2010-02-02T00:00:00Z","timestamp":1265068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2010,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Approximately 66,000 Americans develop non\u2010Hodgkin lymphoma (NHL) each year. Although the use of unlabeled antibodies such as rituximab has significantly improved survival when combined with standard chemotherapy regimens, approximately two\u2010thirds of lymphoma patients eventually develop disease recurrence and die of their disease. Novel treatments are urgently needed to cure these patients. One strategy involves the use of radiolabeled immunoconjugates that specifically localize radiation delivery to sites of lymphoma while minimizing toxicity to normal tissues. A growing number of studies support the contention that radiolabeled antibody therapy can improve overall survival of lymphoma patients and lead to durable remissions, with probable cures, in many patients. Various approaches for enhancing the effectiveness of radioimmunoconjugates have been studied, including: use in newly diagnosed lymphoma patients, combination with chemotherapy or other monoclonal antibodies, use with hematopoietic stem cell transplantation, multistep pretargeting strategies to further minimize toxicity, and simultaneous targeting of multiple B\u2010cell antigens. This article summarizes the current knowledge supporting the use of radioimmunotherapy, an underused but effective treatment modality in NHL patients. Cancer 2010;116(4 suppl):1126\u201333. \u00a9 2010 American Cancer Society.<\/jats:p>","DOI":"10.1002\/cncr.24801","type":"journal-article","created":{"date-parts":[[2010,2,2]],"date-time":"2010-02-02T14:53:17Z","timestamp":1265122397000},"page":"1126-1133","source":"Crossref","is-referenced-by-count":18,"title":["Improving the efficacy of radioimmunotherapy for non\u2010Hodgkin lymphomas"],"prefix":"10.1002","volume":"116","author":[{"given":"M. Corinna A.","family":"Palanca\u2010Wessels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver W.","family":"Press","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,2,2]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/CA.2007.0010"},{"key":"e_1_2_10_3_2","first-page":"17","article-title":"Pilot studies of radioimmunotherapy of B cell lymphoma and leukemia using I\u2010131\u2010Lym1 monoclonal antibody","volume":"1","author":"DeNardo SJ","year":"1988","journal-title":"Antibody Immunoconjugates Radiopharmaceuticals."},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.10.3246"},{"key":"e_1_2_10_5_2","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1182\/blood.V96.4.1259","article-title":"Radioimmunotherapy with iodine I tositumomab for relapsed or refractory B\u2010cell non\u2010Hodgkin lymphoma: updated results and long\u2010term follow\u2010up of the University of Michigan experience","volume":"96","author":"Kaminski MS","year":"2000","journal-title":"Blood."},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.7.1974"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.19.3918"},{"issue":"6","key":"e_1_2_10_8_2","first-page":"74","article-title":"The use of ibritumomab tiuxetan radioimmunotherapy for patients with relapsed B\u2010cell non\u2010Hodgkin's lymphoma","volume":"27","author":"Witzig TE","year":"2000","journal-title":"Semin Oncol."},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.11.017"},{"key":"e_1_2_10_10_2","first-page":"457","article-title":"Yttrium\u201090\u2010labeled anti\u2010CD20 monoclonal antibody therapy of recurrent B\u2010cell lymphoma","volume":"2","author":"Knox SJ","year":"1996","journal-title":"Clin Cancer Res."},{"key":"e_1_2_10_11_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.00.9217"},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.11.076"},{"key":"e_1_2_10_13_2","first-page":"526","article-title":"Three methods to assess red marrow dosimetry in lymphoma patients treated with RIT","volume":"23","author":"Ferrer L","year":"2008","journal-title":"Cancer Biother Radiopharm."},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041511"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.05.8198"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.14.803"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2004.22.14_suppl.6520"},{"key":"e_1_2_10_18_2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2005.23.16_suppl.6577"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0529"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.2015"},{"volume-title":"Malignant Lymphomas: Etiology, Immunology, Treatment","year":"1982","author":"Kaplan HS","key":"e_1_2_10_21_2"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199310213291702"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92225-3"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.10.3270"},{"key":"e_1_2_10_25_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.9.2934"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-1310"},{"key":"e_1_2_10_27_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.2245"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.8294"},{"key":"e_1_2_10_29_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.9248"},{"key":"e_1_2_10_30_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.8.2535"},{"key":"e_1_2_10_31_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0874"},{"key":"e_1_2_10_32_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-11-056895"},{"key":"e_1_2_10_33_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.4.1802"},{"key":"e_1_2_10_34_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.8471"},{"key":"e_1_2_10_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1322"},{"key":"e_1_2_10_36_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0600982103"},{"key":"e_1_2_10_37_2","first-page":"437","article-title":"Comparison of immunoscintigraphy, efficacy, and toxicity of conventional and pretargeted radioimmunotherapy in CD20\u2010expressing human lymphoma xenografts","volume":"44","author":"Subbiah K","year":"2003","journal-title":"J Nucl Med."},{"key":"e_1_2_10_38_2","first-page":"383","article-title":"Radioimmunotherapy of non\u2010Hodgkin's lymphoma revisited","volume":"46","author":"Goldenberg DM","year":"2005","journal-title":"J Nucl Med."},{"key":"e_1_2_10_39_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-0080"},{"key":"e_1_2_10_40_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-11-187401"},{"key":"e_1_2_10_41_2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.058602"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.24801","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.24801","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T15:26:59Z","timestamp":1760282819000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.24801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,2]]},"references-count":40,"journal-issue":{"issue":"S4","published-print":{"date-parts":[[2010,2,15]]}},"alternative-id":["10.1002\/cncr.24801"],"URL":"https:\/\/doi.org\/10.1002\/cncr.24801","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"type":"print","value":"0008-543X"},{"type":"electronic","value":"1097-0142"}],"subject":[],"published":{"date-parts":[[2010,2,2]]}}}